Our Goal

We are an Australian contract development and manufacturing organisation (CDMO) specialising in producing nucleic acid products that support the clinical development of therapeutic products. We support our clients by providing scalable manufacturing capacity and help them accelerate innovation in bringing their products from benchtop to bedside or field.

Our goal at Southern RNA is to establish end-to-end manufacturing capabilities in Australia for nucleic acid products such as mRNA and DNA. We strive towards this goal daily by developing and deploying our state-of-the-art bioprocessing technologies, using proprietary manufacturing and analytical approaches, employing a highly-skilled workforce and partnering with an excellent and extensive network of relationships and collaborations. We aim to become a world-leading, customer-focused, end-to-end supplier renowned for the quality of our outputs and efficiency.

Our Competitive Advantages:

PLATFORM TECHNOLOGY – Proven proprietary processes, products, and services to support your nucleic acid vaccine and therapeutic programs and state-of-the-art equipment that enable high quality production from personalised to pandemic scales.
END-TO-END SUPPORT – Construct design support, development services, best-in-class raw materials, GMP final products (coming soon), and regulatory support for you at every stage of your pipeline.
TALENT – World class pan-disciplinary talent across chemistry, biology, biochemistry, biophysics, supply chain, quality management, business development, and more – all working to support you.
TAX INCENTIVE – Australian-based means access to Australia’s Research and Development Tax Incentive programs.